Separation of Powers: How the Loper Decision Transforms the Health Care Industry's Interactions with the Three Branches of Government (On-Demand Webinar)

Date: 08/29/24
Time: On Demand

Closed captions are available.

Overview: For legal and compliance practitioners operating in the health care industry, the Loper decision, overturning the Chevron decision, is perhaps one of the most impactful decisions in decades. Under Chevron, ambiguity in a statute was considered a delegation by Congress to the agency to fill in.  Thus, unless an agency’s decision (or any reinterpretation) of a statute was wholly unreasonable, it would be upheld.  The Loper decision now returns the authority to interpret an ambiguous statute to the courts, with the agency’s interpretation receiving deference based on its power to persuade.  This webinar explores the far-reaching implications of Loper in the context of the health care industry.

Learning Objectives: 

• Jurisprudential trends underscoring concerns leading to Loper decision
• Loper holding and its rationale
  
• Implications for legislation, rulemaking, and litigation
  

Speaker Information:

Brian Stimson, Partner, Arnall Golden Gregory LLP

Andrew Ruskin, Partner, K&L Gates

Nicholas Bath, Partner, Manatt Health

Keri Conley, General Counsel and Executive Vice President Health Care Policy, Georgia Hospital Association

Continuing Education:

CLE: The maximum number of credits available for ON DEMAND is 1.5 for a 60-minute state and 1.8 for a 50-minute state. This self-study course will be available for purchase for approximately one year after the recording date, but state rules on duration of eligibility for CLE-credits differ, so please check with your state before purchasing self-study offerings. 

CPE: CPE credits are not available for on-demand.

CCB: The Compliance Certification Board (CCB)® has approved this event for up to 1.8 NON LIVE CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.